Hydroxychloroquine
Hydroxychloroquine is a pharmaceutical drug with 277 clinical trials. Currently 32 active trials ongoing. Historical success rate of 67.9%.
Success Metrics
Based on 112 completed trials
Phase Distribution
Phase Distribution
57
Early Stage
87
Mid Stage
96
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
59.6%
112 of 188 finished
40.4%
76 ended early
32
trials recruiting
277
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Hydroxychloroquine in ANCA Vasculitis Evaluation
Randomised Evaluation of COVID-19 Therapy
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
Clinical Trials (277)
Hydroxychloroquine in ANCA Vasculitis Evaluation
Randomised Evaluation of COVID-19 Therapy
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Study of the Efficiency of Hydroxychloroquine on the Endothelial Dysfunction and Its Vascular Consequences During the Antiphospholipid Syndrome
Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer
PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma
Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea
Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes
Efficacy and Safety of Baricitinib in Sjogren's Syndrome
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients
Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration
Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Autophagy Maintenance (AUTOMAIN)
Study of Hydroxychloroquine With FOLFIRI and Bevacizumab in DTP-high Metastatic Colorectal Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 277